Sutro Biopharma (STRO) Current Taxes (2023 - 2024)
Sutro Biopharma's (STRO) quarterly Current Taxes came in at $18000.0 in Q4 2024, down 99.88% year-on-year from $15.2 million in Q1 2024, and little changed quarter-over-quarter from $18000.0 in Q3 2024.
Sutro Biopharma (STRO) Current Taxes (2023 - 2024) Analysis & Trends
Sutro Biopharma has disclosed Current Taxes across 2 years of filings, most recently posting $18000.0 for Q4 2024.
- Current Taxes for Q4 2024 came in at $18000.0, down 99.88% year-over-year; the trailing twelve-month figure through Dec 2024 was $18000.0 (down 99.88% YoY), and the FY2024 annual result was $18000.0, down 99.88% from the prior year.
- Current Taxes came in at $18000.0 for Q4 2024 at Sutro Biopharma, roughly flat from $18000.0 in the prior quarter.
- In the past five years, Current Taxes ranged from a high of $15.2 million in Q4 2023 to a low of $11000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 10,460.56 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 19.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Sutro Biopharma | 252.04 Mn | 252.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 18,000.00 |
| Sep 30, 2024 | 18,000.00 |
| Jun 30, 2024 | 11,000.00 |
| Mar 31, 2024 | 15.17 Mn |
| Dec 31, 2023 | 15.17 Mn |